DK147851C - Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr - Google Patents

Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Info

Publication number
DK147851C
DK147851C DK225073A DK225073A DK147851C DK 147851 C DK147851 C DK 147851C DK 225073 A DK225073 A DK 225073A DK 225073 A DK225073 A DK 225073A DK 147851 C DK147851 C DK 147851C
Authority
DK
Denmark
Prior art keywords
nonapeptidamide
hypophyphenic
diagnostication
gonadotropine
deficiency
Prior art date
Application number
DK225073A
Other languages
Danish (da)
English (en)
Other versions
DK147851B (da
Inventor
Mashiko Fujino
Shigeru Kobayashi
Mikihiko Obayashi
Susumu Shinagawa
Tsunehiko Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4268672A external-priority patent/JPS5324423B2/ja
Priority claimed from JP11845272A external-priority patent/JPS5324424B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to DK441083A priority Critical patent/DK149755C/da
Publication of DK147851B publication Critical patent/DK147851B/da
Application granted granted Critical
Publication of DK147851C publication Critical patent/DK147851C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK225073A 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr DK147851C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK441083A DK149755C (da) 1972-04-29 1983-09-27 Analogifremgangsmaade til fremstilling af lhrh-analoge nonapeptidamidderivater eller fysiologisk acceptable salte eller metalkomplekser deraf

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4268672A JPS5324423B2 (xx) 1972-04-29 1972-04-29
JP4268672 1972-04-29
JP11845272 1972-11-24
JP11845272A JPS5324424B2 (xx) 1972-11-24 1972-11-24

Publications (2)

Publication Number Publication Date
DK147851B DK147851B (da) 1984-12-24
DK147851C true DK147851C (da) 1986-03-10

Family

ID=26382407

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225073A DK147851C (da) 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Country Status (17)

Country Link
US (1) US3853837A (xx)
AT (1) AT333988B (xx)
AU (1) AU453931B2 (xx)
CA (1) CA1005815A (xx)
CH (1) CH580065A5 (xx)
CS (1) CS188162B2 (xx)
DE (2) DE2366379C2 (xx)
DK (1) DK147851C (xx)
ES (1) ES414197A1 (xx)
FI (1) FI56676C (xx)
FR (1) FR2183021B1 (xx)
GB (1) GB1403642A (xx)
HU (1) HU168696B (xx)
NL (2) NL176856C (xx)
NO (1) NO139560C (xx)
PL (1) PL95790B1 (xx)
SE (1) SE397520B (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931138A (en) * 1973-03-13 1976-01-06 Abbott Laboratories N-carbobenzoxy-pyroglutamyl-histidine
AT347054B (de) * 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NO302481B1 (no) 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
ES2110573T3 (es) 1992-08-07 1998-02-16 Takeda Chemical Industries Ltd Produccion de microcapsulas de farmacos solubles en agua.
EP0668073B1 (en) * 1994-02-21 1999-04-14 Takeda Chemical Industries, Ltd. Polyester matrix for a pharmaceutical sustained-release preparation
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CA2581287C (en) 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2011506319A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
AU2014233453A1 (en) 2013-03-15 2015-10-01 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados

Also Published As

Publication number Publication date
DE2321174C2 (de) 1982-04-15
NL176856C (nl) 1985-06-17
NO139560B (no) 1978-12-27
HU168696B (xx) 1976-06-28
AU453931B2 (en) 1974-10-17
DE2321174A1 (de) 1973-11-08
SE397520B (sv) 1977-11-07
AT333988B (de) 1976-12-27
DK147851B (da) 1984-12-24
CS188162B2 (en) 1979-02-28
ES414197A1 (es) 1976-05-01
US3853837A (en) 1974-12-10
FI56676C (fi) 1980-03-10
GB1403642A (en) 1975-08-28
NL930004I1 (nl) 1993-04-01
NO139560C (no) 1979-04-04
CH580065A5 (xx) 1976-09-30
FR2183021B1 (xx) 1976-04-09
NL7305995A (xx) 1973-10-31
DE2366379C2 (de) 1985-01-17
CA1005815A (en) 1977-02-22
AU5467673A (en) 1974-10-17
FR2183021A1 (xx) 1973-12-14
ATA377173A (de) 1976-04-15
FI56676B (fi) 1979-11-30
PL95790B1 (pl) 1977-11-30

Similar Documents

Publication Publication Date Title
DK147851C (da) Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr
DK20979A (da) 4-amino-5-alkylsulfonyl-0-anisamid-derivater samt fremgangsmaade til fremstilling deraf
DK93880A (da) Polyolderivater samt deres fremstilling og anvendelse
NL930029I1 (nl) Enzyme derivatives and their preparation
SE418088B (sv) Med glyoxal behandlad akrylpolymer i finfordelad form samt motsvarande framstellningsforfarande
LT2274B (lt) Benzimidazolo dariniu arba ju drusku gavimo budas
DK222382A (da) Benzezepinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK301477A (da) Fremgangsmaade til stereoselektiv fremstilling af hexahydrodibenzopyranoner samt mellemprodukt til brug ved fremgangsmaaden
FI800091A (fi) Saett vid defibrering resp raffinering av lignocellulosahaltiga fibermaterial
MX150412A (es) Mejoras en taco expansible
SE7607107L (sv) Forfarande och anleggning for reglering av fetthalten i mjolk
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
AR221831A1 (es) Composicion conservadora de madera y de productos lenosos
NO149477C (no) Fremgangsmaate for fremstilling av limt papir samt limemiddel for bruk i fremgangsmaaten
CH532031A (de) Verfahren zur Herstellung von in 2-Stellung substituierten 5-Nitro-furan-, 5-Nitro-thiophen- und 5-Nitro-pyrrolderivaten
DK88880A (da) Tetrahydrobenzothiazolylimidazolidioner samt deres anvendelse i herbicider
CH484913A (de) Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
IT971959B (it) Formulazione atta all impiego in isocianurati rigidi e relativi isocianurati rigidi
SE431411B (sv) Gjutningsmaskin samt anvendning av densamma
DK54179A (da) N-azolylalkyl-anillin samt fremgangsmaader til deres fremstilling
CH484912A (de) Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-Anilino-1,3-diazacyclopentens-(2)
DK310074A (da) Ildfast isolationsmateriale samt fremgangsmade til fremstilling af til brug i dette bestemte opblerede partikler
IL32216A0 (en) Derivatives of the 2-(lower alkyl)-3-(lower alkyl)-4-aryl-cyclohexenylcarbinols and their preparation
DK40480A (da) Urinstofderivater samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PUP Patent expired